Davies, LixiLan-O Trial Investigators, Benefits of LixiLan, a titratable fixed-ratio combination of insulin Glargine plus Lixisenatide, versus insulin Glargine and Lixisenatide monocomponents in type 2 diabetes inadequately controlled on oral agents: The LixiLan-O randomized trial
Long-term treatment with liraglutide significantly reduces tau pathology and improves motor function in a transgenic mouse model of tauopathy
doi:10.1039/d0fo02210a Fakhri S, Patra JK, Das SK, Das G, Majnooni MB, Farzaei MH
Liposomal L-Glutathione reduced plays a vital role in the body's detoxification processes
Peer review Peer review information Nature Reviews Nephrology thanks Mark Cooper, Francesco Giorgino and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Severe zinc deficiency is rare in the U.S., but according to NHANES data, approximately 15 percent of U.S